(S)-CR8, CDK 1, 2, 5, 7 and 9 inhibitor (ab144231)

Overview

  • Product name

    (S)-CR8, CDK 1, 2, 5, 7 and 9 inhibitor
  • Description

    Potent, selective, cell-permeable cyclin-dependent kinase (CDK) 1, 2, 5, 7 and 9 inhibitor
  • Biological description

    Potent, selective, cell-permeable cyclin-dependent kinase (CDK) 1, 2, 5, 7 and 9 inhibitor (IC50 = 41 - 400 nM). (R)-DRF053 (ab141505) analog. More potent than roscovirtine. Apoptosis inducer. GSK-3α/β (glycogen synthase kinase-3α/β) inhibitor. Antitumor potential.

    See similar compound
  • Purity

    > 98%
  • CAS Number

    1084893-56-0
  • Chemical structure

    Chemical Structure

Properties

  • Chemical name

    (2S)-2-[[9-Propan-2-yl-6-[(4-pyridin-2-ylphenyl)methylamino]purin-2-yl]amino]butan-1-ol
  • Molecular weight

    431.53
  • Molecular formula

    C24H29N7O
  • PubChem identifier

    25211051
  • Storage instructions

    Store at -20°C. Store In the Dark. Store under desiccating conditions. This product is air and light sensitive and impurities can occur as a result of air oxidation or due to metabolism by microbes.
  • Solubility overview

    Soluble in ethanol to 25 mM and in DMSO to 10 mM
  • Handling

    Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

    Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

  • SMILES

    CC[C@@H](CO)NC1=NC2=C(C(=N1)NCC3=CC=C(C=C3)C4=CC=CC=N4)N=CN2C(C)C
  • Source

    Synthetic

References

This product has been referenced in:

  • Bukanov NO  et al. CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD. Cell Cycle 11:4040-6 (2012). Read more (PubMed: 23032260) »
  • Besson A  et al. CDK inhibitors: cell cycle regulators and beyond. Dev Cell 14:159-69 (2008). Read more (PubMed: 18267085) »
  • Bettayeb K  et al. CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases. Oncogene 27:5797-807 (2008). Read more (PubMed: 18574471) »

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab144231.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

Sign up